These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18156024)

  • 1. War on white coats.
    Simmons N
    Lancet; 2007 Dec; 370(9605):2098. PubMed ID: 18156024
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital.
    Freeman J; Stott J; Baines SD; Fawley WN; Wilcox MH
    J Antimicrob Chemother; 2005 Nov; 56(5):988-9. PubMed ID: 16195254
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
    Cunningham R
    CMAJ; 2006 Sep; 175(7):757. PubMed ID: 17001056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Debatable questions on Clostridium difficile diarrhea].
    Burman LG
    Lakartidningen; 1992 Jan; 89(4):196-7. PubMed ID: 1734150
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and management of patients with Clostridium difficile-associated diarrhoea.
    Hall J; Horsley M
    Nurs Stand; 2007 Jul 25-31; 21(46):49-56; quiz 58. PubMed ID: 17711247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Brazier JS; Stubbs SL; Duerden BI
    J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cephalosporins--a common cause of nosocomial Clostridium difficile diarrhea].
    Sandberg T; Hallén I; Larsson P
    Lakartidningen; 1992 Jan; 89(3):109-10. PubMed ID: 1734138
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the war being won?--An expert's view.
    Duerden B
    Health Estate; 2009 Mar; 63(3):59-61. PubMed ID: 19344002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
    Pakyz AL; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Infect Control Hosp Epidemiol; 2010 Aug; 31(8):867-8. PubMed ID: 20586649
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile infection following hip fracture.
    Fenton P; Singh K; Cooper M
    J Hosp Infect; 2008 Apr; 68(4):376-7. PubMed ID: 18353494
    [No Abstract]   [Full Text] [Related]  

  • 11. Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012.
    Plaza-Garrido Á; Barra-Carrasco J; Macias JH; Carman R; Fawley WN; Wilcox MH; Hernández-Rocha C; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Epidemiol Infect; 2016 Apr; 144(5):976-9. PubMed ID: 26489717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C. difficile rates in hospital higher than expected.
    Hosp Health Netw; 2008 Dec; 82(12):47. PubMed ID: 19227581
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomembranous colitis associated with ciprofloxacin.
    Cain DB; O'Connor ME
    Lancet; 1990 Oct; 336(8720):946. PubMed ID: 1976960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands].
    Kuijper EJ; Debast SB; Van Kregten E; Vaessen N; Notermans DW; van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2087-9. PubMed ID: 16201596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors and the risk for Clostridium difficile infection.
    Famularo G; Gasbarrone L; De Simone C
    JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
    [No Abstract]   [Full Text] [Related]  

  • 16. Data briefing. The trouble with assessing risk.
    Appleby J; Thorlby R
    Health Serv J; 2007 Dec; Suppl():5. PubMed ID: 18260602
    [No Abstract]   [Full Text] [Related]  

  • 17. Substantial variation in hospital rankings after adjusting for hospital-level predictors of publicly-reported hospital-associated Clostridium difficile infection rates.
    Datta R; Kazerouni NN; Rosenberg J; Nguyen VQ; Phelan M; Billimek J; Cao C; McLendon P; Cummings K; Huang SS
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):464-6. PubMed ID: 25782902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Clostridium difficile virulence demands new treatment approach.
    Voelker R
    JAMA; 2010 May; 303(20):2017-9. PubMed ID: 20501917
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Clostridium difficile the leading pathogen in bacterial diarrhea in HIV type 1-infected patients?
    Torre D
    Clin Infect Dis; 2006 Apr; 42(8):1215-6; author reply 1216. PubMed ID: 16575754
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pseudomembranous colitis: pathogenesis, prevention, treatment].
    Zakharova NV; Fil' TS
    Eksp Klin Gastroenterol; 2013; (12):87-91. PubMed ID: 24933996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.